Information for immunocompromised individuals regarding the prevention and treatment of SARS-CoV-2 infection in the context of currently circulating Omicron sublines – United States, January 2023
BOX. SARS-CoV-2 prevention measures for immunocompromised individuals, their household members, and close contacts in the context of currently circulating Omicron sublines — United States, January 2023 Because Evusheld is not currently cleared for pre-exposure prophylaxis against SARS-CoV-2 infection in the United States, it is important that moderately to severely immunocompromised individuals,* those who may have … Read more
